PD 155080

Known as: PD-155080 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2004
01219952004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
We have documented the effects of long-term endothelin receptor antagonism on intracellular Ca2+ regulation and Ca2+ regulatory… (More)
Is this relevant?
2002
2002
We studied the effect of long-term treatment with the oral endothelin (ET) ET(A) antagonist 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4… (More)
Is this relevant?
1999
1999
The endothelin system is highly activated during endotoxin and septic shock. To investigate this matter the selective non-peptide… (More)
Is this relevant?
1999
1999
Porcine endotoxin shock is characterized by pulmonary hypertension, decreased mean arterial pressure and deteriorated cardiac… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
1998
1998
BACKGROUND Circulating endothelin (ET)-1 is elevated in ischemia/reperfusion and may exert proischemic effects. The aim of the… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Experiments in cultured vascular smooth muscle cells have shown that angiotensin II (Ang II) stimulates expression of endothelin… (More)
Is this relevant?
1997
1997
Surgical ablation of renal mass leads to a reduction in kidney function and commonly to the development of hypertension and… (More)
Is this relevant?
1996
1996
The effects of two endothelin (ET) receptor antagonists, PD 155080 (ET(A) selective) and BQ-788 (ET(B) selective), on cardiac… (More)
Is this relevant?
1995
1995
The development of nonpeptide, low molecular weight antagonists with high potency, oral activity, and selectivity is an important… (More)
Is this relevant?